Figs reported second-quarter revenue of $196.6 million, beating analyst estimates of $186.1 million and marking 28.8% year-on-year growth. The healthcare apparel company's adjusted earnings per share came in at $0.11, surpassing expectations of $0.07. CEO Trina Spear attributed the results to broad-based growth across product categories, channels and geographies. Active customers reached 3.1 million, up 360,000 year on year, whilst net revenues per active customer hit an all-time high. The company achieved substantial margin expansion through improved full-price selling, lower return rates and operational efficiencies. Operating margin increased to 17.9%, up from 6.5% in the same quarter last year. Figs addressed supply chain disruption in Jordan by shifting production to other partners and expediting shipments. Management highlighted international expansion, retail stores and institutional sales as key long-term growth vectors.

FIGS reported second-quarter 2026 results that exceeded expectations, with net revenues growing 29% to $197 million. The healthcare apparel company marked its third consecutive quarter of growth above 25%, representing its strongest sustained growth period since 2021. Co-founder and chief executive officer Catherine Spear highlighted the broad-based nature of the company's momentum during the earnings call. Growth was driven across multiple business segments, including various channels, product categories, geographies, and customer cohorts. The company beat its own outlook for the quarter. FIGS released its results alongside a shareholder presentation posted to its investor relations website. Chief financial officer Sarah Oughtred also participated in the earnings call.

FIGS stock surges after big earnings beat and upgraded outlook. TIM SYKES - UPDATED AUG. 9, 2026, 10:08 AM ET FIGS Inc. stocks have been trading up by 28.71 percent, propelled by upbeat news signaling strengthening demand and investor confidence. What traders need to know. * Q2 earnings smashed expectations with EPS of $0.15 vs $0.07 and revenue of $196.6M vs $186.1M, delivering a third straight quarter of 25%+ net revenue growth and 18.6% EBITDA margin. * Management raised its FY26 outlook to about 20% revenue growth and lifted the adjusted EBITDA margin target to 14.8%-15% from 13%-13.2%. * Shares of FIGS Inc. jumped nearly 28% after the Q2 beat, with strong year-over-year growth and better profitability sparking aggressive buying. * Multiple firms, including BTIG, KeyBanc, Barclays, Roth Capital, and Goldman Sachs, raised price targets on FIGS after the report, several reiterating Buy or Overweight ratings. * One counterpoint came from Telsey Advisory, which trimmed its target to $16 and kept a Market Perform rating, flagging macro and supply chain risks despite the strong quarter. Weekly Update Aug 03 - Aug 07, 2026: On Sunday, August 09, 2026 FIGS Inc. stock [NYSE: FIGS] is trending up by 28.71%! Discover the key drivers behind this movement as well as its expert analysis in the detailed breakdown below. Consumer Discretionary industry expert: Analyst sentiment - positive FIGS stands as a scaled, profitable niche leader in premium medical apparel, combining DTC DNA with increasingly diversified channels. Revenue of ~$631M with mid-teens multi-year CAGR, gross margin of 66.6%, and Q2 EBIT margin above the 6.1% full-year level underscore strong unit economics. Returns on equity around 10% and ROIC ~6% are healthy for an asset-light model, while leverage is negligible (D/E 0.14, current ratio 5.4). Free cash flow of ~$44M in Q2 supports continued reinvestment and optionality around capital returns. Technically, FIGS has shifted decisively into a momentum uptrend. This week's move from ~$11 to $14.47, with the 8/6 gap and expansion candle on heavy volume, confirms a breakout from a multi-month base. Intraday 5-minute action shows persistent dip-buying above $13.50 with rising volume into the close, signaling strong institutional demand. For traders, $13.80-14.00 is the critical first support; a sustained hold above this zone favors a measured long with a tight stop just below $13.40. Fundamentally and relative to Consumer Discretionary and Apparel & Luxury peers, FIGS screens as a premium-multiple growth compounder. Three consecutive quarters of 25%+ net revenue growth, Q2 EPS beat (0.15 vs 0.07), and EBITDA margin expansion to ~18.6% justify its high P/E versus slower-growing apparel names. Raised FY26 guidance (≈20% revenue growth, higher margin targets) plus multiple Buy-rated PT hikes support further re-rating. I see near-term resistance at $16.50-17 and an achievable 6-12 month target of $20. Quick financial overview. FIGS Inc. delivered a clean beat in Q2, printing $196.6M in revenue versus roughly $186M expected and EPS of $0.15 versus $0.07. That put net revenue growth north of 25% for the third quarter in a row and pushed adjusted EBITDA margin to 18.6%, a strong level for an apparel-focused brand. With gross margin around 66.6% and profit margin in the mid-single digits, the model is clearly built on high product markup and ongoing operating leverage. From a balance sheet view, FIGS Inc. carries modest leverage, with total debt to equity at 0.14 and a current ratio of 5.4. Cash and short-term investments sit comfortably above $250M, and Q2 free cash flow of about $44.3M shows the brand is converting earnings into cash. Returns on equity and assets are positive and improving, helped by asset turnover of 1.2, which tells traders the business is using its asset base fairly efficiently for a growth story. On the tape, the Q2 report acted like a reset. Weekly data show FIGS stock grinding near $11 before the release, then exploding to a $14.90 high and holding above $14 into the week's close. Intraday, price spiked from the low teens to above $16.30 before backing off to the mid-$14s, a classic earnings gap plus run with some profit-taking. With a price-to-sales ratio near 3.6 and a rich P/E near 67.9, the stock is priced for continued growth, which puts extra weight on each future quarter for momentum traders. Conclusion. This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Its content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to Millionaire Media, LLC. for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize its news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities. Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles: Once you've got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market's twists and turns. Dig into StocksToTrade's watchlists here: Buy this stock for a monster Monday move. Want to start next week off with a big win? Its new algorithm may have just uncovered a new dirt-cheap stock with a great chance of moving +100% or more this Monday. ...One ticker...One trade...One MONSTER move... All you have to do is make this one trade on Monday. While I can't promise future performance, previous picks from this new Monday Algo have racked up gains of +149%, +190%, and +536%... in as little as one day. And Millionaire Media, LLC. think this new pick could be just as big. But if Millionaire Media, LLC. is right, it may move FAST... How much has this post helped you? (0 votes, average: 0 out of 5)